← All companies
NOVAVAX INC
NVAX - CIK 0001000694
Market cap$1.48 B
Rank#2343
SEC filings1,627
The table below shows NOVAVAX INC's balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $228.36M | $268.02M | $253.74M | $263.34M | $573.63M | $680.16M |
| Short-term investments | $561.97M | $494.87M | $358.56M | $468.14M | $335.90M | $369.43M |
| Receivables | - | - | - | - | - | - |
| Inventory | $11.46M | $13.51M | $10.24M | $10.26M | $8.64M | $9.17M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.